About

Provided by Epstein Rosenblum Maoz (ERM)

High-Tech & Venture Capital: ERM advises technology clients in all stages of development, from inception to exit and beyond, and offers in-depth experience and expertise in the high-tech, cleantech, and life sciences sectors. ERM also regularly acts for leading venture capital funds and institutional investors in a wide range of investments in technology companies at all stages. The department performs holistic legal work, from venture capital and venture debt to start-up representation, commercial technology transactions, data, privacy & cybersecurity, healthcare and life sciences, and regulation. 


Corporate, M&A & Private Equity: ERM provides comprehensive Corporate & Commercial Services, complementing their High Tech & Venture Capital. The department showcases extensive experience advising complex cross-border M&A and private equity transactions, as well as on all aspects of corporate law, data protection and cyber security matters. ERM has advised international and Israeli buyers, sellers, investment banks, and financial institutions on a wide range of high-profile public and private transactions, including share and asset sales, takeovers, leveraged and management buyouts, and demergers. Their legal service includes corporate governance, crisis management, representation of foreign companies in Israel, and commercial agreements. Additionally, ERM’s M&A practice focuses on mergers and acquisitions, private equity, joint ventures, and institutional investors. 

Chambers Review

Provided by Chambers

Startups & Emerging Companies - Israel

4
Band 4

What the Team is Known For

Epstein Rosenblum Maoz (ERM) houses a skilled group with particular experience in advising a range of clients, including tech funds, venture capital funds and private equity funds, on their investments into startup companies. The firm is based in Tel Aviv and has noteworthy experience in assisting startups with day-to-day corporate activities, as well as their investment rounds. Its lawyers are proficient in the representation of young companies from the cybersecurity and healthcare fields.

Work Highlights

  • Epstein Rosenblum Maoz (ERM) assisted TeleMessage and its shareholders in relation to Smarsh's rights to acquire 51% of the company, following a previous 49% equity sale.

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers

Simon Marks
5
Simon Marks
5
Band 5

Simon Marks heads the startups department at Epstein Rosenblum Maoz. He is particularly well regarded for his experience advising on regulatory matters, M&A and funding rounds.

Simon is a brilliant lawyer with global legal and commercial awareness. He is a very capable communicator and friendly personality - a joy to work with.

Simon is highly knowledgeable and brings a strategic approach to legal challenges. His responsiveness, attention to detail and ability to anticipate potential issues make him an invaluable adviser.

Simon Marks is amazing. He knows what he is doing and is a great business partner. He deserves every compliment I could give to him.

Simon always provides impeccable service.

Ranked Lawyers at
Epstein Rosenblum Maoz (ERM)

Provided by Chambers
Filter by
Band

Israel

Startups & Emerging Companies

Simon Marks
5
Simon Marks
5
Band 5

Members

Provided by Epstein Rosenblum Maoz (ERM)

Jeremy Seeff

Nimrod Rosenblum

Roni Abelski

Rotem Perelman Farhi

Simon Marks

Head of Department

Yoel Lavie

Clients

Provided by Epstein Rosenblum Maoz (ERM)

ALTANA

Alive HealthTech Fund

Altiris Technologies

Aquila Investments Opportunity

BVI Medical

Blackstone

Bookaway

Daimler

Deutsche Boerse

Fresenius Medical Care Ventures

Future Energy Ventures

Go To Global

Happiness Capital

Henkel

Innogy

Intelligo Group

Karamba Security

Lime

LoudClear

REWE Group

SoftBank

Industries

Provided by Epstein Rosenblum Maoz (ERM)

Commercial Technology Transactions

Data, Privacy, & Cybersecurity

Healthcare and Life Sciences

Investment Funds

Start-Up Representation

Startup Regulation

Venture Capital and Venture Debt